BioReference Laboratories Supports Man Cave Health During National Men’s Health Month
ELMWOOD PARK, N.J., June 07, 2019 (GLOBE NEWSWIRE) — BioReference Laboratories, Inc., alongside its specialty oncology and urology department, GenPath, announce today their aid of Man Cave Health’s upcoming charity golf match for Men’s Health Month, discovered yearly within the United States all through the month of June. The occasion will take region on Monday, June 10, 2019, on the Fresh Meadow Country Club in Lake Success, New York. BRL and GenPath will participate in the event by imparting complimentary, on-website Prostate Specific Antigen (PSA) checking out to all participants.
A PSA blood check is general of taking care of prostate cancer screening, a vital first step within the identification and diagnosis of prostate cancer, with most countrywide pointers recommending trying out for guys between a long time of forty-five and seventy-five. Men in better danger classes, consisting of African Americans and those with a family record of the disease, should discuss with their physicians approximately screening tips.
“Total PSA is commonly elevated in patients with prostate cancer; however, an improved PSA is nonspecific and can be visible in some of the non-cancerous situations which include an enlarged prostate and prostatitis, which do not benefit a biopsy or remedy,” said James Weisberger, M.D., Chief Medical Officer of BioReference Laboratories. “Patients with an extended PSA or different risk factors, which includes an advantageous Digital Rectal Exam, may be a candidate for the 4Kscore Test, blood takes a look at imparting a man his customized threat of finding aggressive prostate cancer if a biopsy had been to be done. The 4Kscore Test gives a greater correct evaluation of competitive prostate most cancers chance, permitting healthcare carriers to greater hopefully manage low hazard patients, and do not forget prostate biopsy and different observe-up in better risk men.”
Man Cave Health was launched in 2018, through the Milana Family Foundation. Its project is to force a robust communication about guys’ fitness, consisting of preventive care, among guys and their families and most importantly, their physicians. By supplying loose PSA screening, a crucial first step in the identity and prognosis of prostate cancer, BRL and its GenPath division are immediately contributing to the achievement of Man Cave’s project.
PSA and 4Kscore testing are available at BioReference thru its forte oncology and urology department, GenPath. For greater data approximately the 4Kscore take a look at,
About the 4Kscore Test
The 4Kscore is a blood take a look at that offers a personalized hazard evaluation of locating aggressive prostate most cancers if a biopsy has been to be finished. The 4Kscore Test includes the measurements of 4 unique prostate biomarkers together with clinical records, and can be utilized in men who’ve by no means had a prostate biopsy or guys with earlier terrible biopsy effects. Providing the hazard of competitive most cancers after a peculiar PSA or DRE, 4Kscore facts allow medical doctors and patients avoid prostate biopsies in low danger men, while identifying men at excessive danger for a competitive form of prostate most cancers for also paintings up. For greater information,
About Man Cave Health
The Milana Family Foundation released its most recent initiative, Man Cave Health, in 2018. Driven by way of the belief that “guys take better care of their automobiles than they do their our bodies,” its reason is to train guys approximately prostate health and encourage men to be extra proactive in sharing health concerns with their vendors. This initiative started after Thomas Milana, Jr. Became identified with prostate most cancers, and in navigating his manner from analysis lower back to well-being, an increasing number of saw the need for more discussion around guys’ fitness issues. For greater information about Man Cave Health and The Milana Family Foundation
About BioReference Laboratories, Inc.
BioReference affords comprehensive testing to physicians, clinics, hospitals, employers, authorities units, correctional establishments and medical organizations. The enterprise is in community with the five biggest fitness plans within the United States, operates a community of eleven laboratory locations, and is backed with the aid of a clinical group of workers of greater than 160 MD, PhD and different expert degree clinicians and scientists. With a main position inside the areas of genetics, ladies’ health, maternal-fetal medication, oncology and urology, BioReference and its area of expertise laboratories, GenPath and GeneDx, are advancing the path of current remedy. For greater informationCautionary Statement Regarding Forward-Looking Statements
This press launch includes “forward-searching statements,” as that term is described under the Private Securities Litigation Reform Act of 1995 (PSLRA), which statements can be diagnosed by way of phrases including “expects,” “plans,” “tasks,” “will,” “may also,” “anticipates,” “believes,” “have to,” “intends,” “estimates,” and other phrases of comparable which means, together with statements about expectations for BioReference, our diagnostic checking out offerings and their advantages, along with the benefits of the 4Kscore check, as well as different non-historic statements about our expectations, beliefs or intentions. Many factors could cause our real activities or consequences to vary materially from the activities and outcomes expected in ahead-looking statements. These factors include those described inside the OPKO Health, Inc. Annual Reports on Form 10-K filed and to be filed with the Securities and Exchange Commission and in our other filings with the Securities and Exchange Commission. Forward-looking statements may also be adversely stricken by popular market elements, competitive product improvement, product availability, federal and kingdom guidelines and law, the regulatory technique for brand spanking new merchandise and indicators, manufacturing issues that could stand up, patent positions and litigation, amongst different factors. The ahead-looking statements contained on this press release speak only as of the date the statements have been made, and we do now not undertake any responsibility to update forward-searching statements. We intend that all forward-searching statements be subject to the safe-harbour provisions of the PSLRA.